These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease]. Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935 [TBL] [Abstract][Full Text] [Related]
6. Infantile Pompe disease with intrauterine onset: a case report and literature review. Xi H; Li X; Ma L; Yin X; Yang P; Zhang L Ital J Pediatr; 2022 Nov; 48(1):187. PubMed ID: 36411466 [TBL] [Abstract][Full Text] [Related]
7. [Pompe disease treated with enzyme replacement therapy in pregnancy]. Grosz Z; Várdi KV; Molnár JM Ideggyogy Sz; 2020 Sep; 73(9-10):339-344. PubMed ID: 33035415 [TBL] [Abstract][Full Text] [Related]
8. Pompe disease: a review of the current diagnosis and treatment recommendations in the era of enzyme replacement therapy. Katzin LW; Amato AA J Clin Neuromuscul Dis; 2008 Jun; 9(4):421-31. PubMed ID: 18525427 [TBL] [Abstract][Full Text] [Related]
10. Non-specificity of symptoms in infantile-onset Pompe disease may delay the diagnosis and institution of treatment. Senarathne UD; Jasinge E; Viknarajah Mohan S; Waidyanatha S BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35264382 [TBL] [Abstract][Full Text] [Related]
12. Low anal sphincter tone in infantile-onset Pompe Disease: an emerging clinical issue in enzyme replacement therapy patients requiring special attention. Tan QK; Cheah SM; Dearmey SM; Kishnani PS Mol Genet Metab; 2013 Feb; 108(2):142-4. PubMed ID: 23266370 [TBL] [Abstract][Full Text] [Related]
13. Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy. van der Beek NA; Hagemans ML; van der Ploeg AT; Reuser AJ; van Doorn PA Acta Neurol Belg; 2006 Jun; 106(2):82-6. PubMed ID: 16898258 [TBL] [Abstract][Full Text] [Related]
14. Spanish Pompe registry: Baseline characteristics of first 49 patients with adult onset of Pompe disease. Alonso-Pérez J; Segovia S; Domínguez-González C; Olivé M; Mendoza Grimón MD; Fernández-Torrón R; López de Munain A; Muñoz-Blanco JL; Ramos-Fransi A; Almendrote M; Illa I; Díaz-Manera J Med Clin (Barc); 2020 Feb; 154(3):80-85. PubMed ID: 31253477 [TBL] [Abstract][Full Text] [Related]
15. Infantile Pompe disease on ERT: update on clinical presentation, musculoskeletal management, and exercise considerations. Case LE; Beckemeyer AA; Kishnani PS Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):69-79. PubMed ID: 22252989 [TBL] [Abstract][Full Text] [Related]
16. Three cases of multi-generational Pompe disease: Are current practices missing diagnostic and treatment opportunities? McIntosh P; Austin S; Sullivan J; Bailey L; Bailey C; Viskochil D; Kishnani PS Am J Med Genet A; 2017 Oct; 173(10):2628-2634. PubMed ID: 28763149 [TBL] [Abstract][Full Text] [Related]
17. Enzyme replacement therapy for infantile Pompe disease during the critical period and identification of a novel mutation. But WM; Lee SH; Chan AO; Lau GT Hong Kong Med J; 2009 Dec; 15(6):474-7. PubMed ID: 19966354 [TBL] [Abstract][Full Text] [Related]
18. [A retrospective study of six patients with late-onset Pompe disease]. Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925 [TBL] [Abstract][Full Text] [Related]
19. Perioperative management of children with glycogen storage disease type II-Pompe disease. Bosman L; Hoeks SE; González Candel A; van den Hout HJM; van der Ploeg AT; Staals LM Paediatr Anaesth; 2018 May; 28(5):428-435. PubMed ID: 29575534 [TBL] [Abstract][Full Text] [Related]
20. Infantile Pompe disease: clinical and genetic characteristics with an experience of enzyme replacement therapy. Cho A; Kim SJ; Lim BC; Hwang H; Park JD; Kim GB; Jin DK; Lee J; Ki CS; Kim KJ; Hwang YS; Chae JH J Child Neurol; 2012 Mar; 27(3):319-24. PubMed ID: 21940687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]